Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

April 22, 2011

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

April 19, 2011

Peppermint earns respect in mainstream medicine
Peppermint is now clinically proven to be an effective pain reliever for Irritable Bowel Syndrome.
Read article at medicalxpress.com

April 12, 2011

Research Review Finds Lycopene Benefits High Blood Pressure and Cholesterol
High cholesterol and high blood pressure are “major risk factors” for cardiovascular disease and stroke which cause nearly 38% of all deaths in the United States each year and cost our healthcare system $403 billion and $43 billion each year. The American Heart Association’s recommendations are (no higher than) 200 mg/dL for total cholesterol levels while classifying” high cholesterol” as at least 240 mg/dL. “Optimal” HDL and LDL cholesterol levels are at least 60 mg/dL and no higher than 100 mg/DL, respectively. Now a new study has found that lycopene may help keep both cholesterol and blood pressure in healthy ranges.
Read article on the website of the Natural Health Research Institute (USA)

February 7, 2011

The Alternative Approach: Find Relief from Chronic Cough with Vitamin B12
Is it possible that a B vitamin can reduce or cure a chronic cough? According to one medical study, the answer is yes.
Read article on the website of the Natural Health Research Institute (USA)

For more natural health news, click here.

See also our 2001-2010 news archive, by clicking here.

Pharma "Business with Disease" News

April 19, 2011

Bowel Drugs Side Effects May Cause Fatal Blood Cancer: FDA Warns
Federal drug regulators are receiving an increasing amount of blood cancer reports from users of some drugs designed to treat inflammatory bowel disease (IBD). The FDA issued a drug safety alert on April 14 for tumor necrosis factor (TNF) blockers, including Cimzia, Enbrel, Humira, Remicade and Simponi, as well as other types of drugs like azathioprine and mercaptopurine. The agency says a number of reports have linked the drugs to a rare cancer of white blood cells in children and young adults known as Hepatosplenic T-Cell Lymphoma (HSTCL).
Read article at aboutlawsuits.com (USA)

April 14, 2011

FDA Urged To Ban Diet Pill Over Liver Damage
For the second time in five years, Public Citizen is petitioning the FDA to ban the Xenical prescription diet pill sold by Roche, which is also marketed in a lower-dose, over-the-counter version as Alli by GlaxoSmithKline. The latest move comes after a report earlier this week that linked the drug to kidney stones and pancreatic damage. The watchdog group identified 47 cases of acute pancreatitis and 73 kidney stones among patients taking either the prescription version or the over-the-counter form.
Read article at pharmalot.com

April 13, 2011

Foundations, Conflicts Of Interest And Drugmakers
Major philanthropic foundations, such as the Bill & Melinda Gates Foundation, regularly make the news with their donations and initiatives aimed at improving global health. But there is an aspect to their efforts that may be overlooked - such organizations can have links with drugmakers that could constitute a conflict of interest, according to an analysis published in PLoS Medicine.
Read article at pharmalot.com
Comment: The PLoS analysis adds significantly to the information about the Gates Foundation that was published by the Los Angeles Times in January 2007. In particular, the researchers found that several members of the Gates Foundation’s management committee, leadership teams, affiliates, and major funders are currently or were previously members of the boards or executive branches of major drugmakers, including Merck and Novartis. To examine the commercial network of the Bill & Melinda Gates Foundation, click here and here. For further information about Bill Gates, click here.

For more pharma "business with disease" news, click here.

See also our 2001-2010 news archive, by clicking here.

GMO News

April 15, 2011

BASF buys rights to another GMO potato
German chemicals group BASF said on Friday it had acquired ownership rights to another type of potato containing genetically-modified organisms (GMOs).
Read news report at reuters.com

April 7, 2011

GMOs Linked to Organ Disruption in 19 Studies
A new paper shows that consuming genetically modified (GM) corn or soybeans leads to significant organ disruptions in rats and mice, particularly in livers and kidneys. By reviewing data from 19 animal studies, Professor Gilles-Eric Séralini and others reveal that 9% of the measured parameters, including blood and urine biochemistry, organ weights, and microscopic analyses (histopathology), were significantly disrupted in the GM-fed animals. The kidneys of males fared the worst, with 43.5% of all the changes. The liver of females followed, with 30.8%. The report, published in Environmental Sciences Europe on March 1, 2011, confirms that “several convergent data appear to indicate liver and kidney problems as end points of GMO diet effects.” The authors point out that livers and kidneys “are the major reactive organs” in cases of chronic food toxicity.
Read article by Jeffrey Smith on the Institute for Responsible Technology website (USA)

For more GMO news, click here.

See also our 2001-2010 news archive, by clicking here.

Other Health-related News

April 18, 2011

Use of pesticides in Brazil continues to grow
Another year passes and still Brazil maintains its ranking as the world's largest consumer of pesticides, first attained in 2008. An unenviable record, the consequences of which are now starting to become clearer to the wider public.
According to data from the Union of Agrochemical Industries (Sindag), 986,500 tons of pesticides were consumed in 2008 and more than a million tons in 2009 (equivalent to 5.2 kg of agrochemical products per Brazilian per year).
Read article at gmwatch.org

April 12, 2011

Study: More than half of U.S. adults over 20 take vitamins
More than half of U.S. adults age 20 and older take vitamins or other dietary supplements, a new government study shows. The percentage who took at least one dietary supplement increased to 53% in 2006, up from 42% in 1994.
Read article in USA Today

For more health-related news, click here.

See also our 2001-2010 news archive, by clicking here.

Political News

April 19, 2011

Web creator's net neutrality fear
The inventor of the web has said that governments must act to preserve the principle of net neutrality. Sir Tim Berners-Lee told the BBC that legislation may be needed if self-regulation failed.
Read article on the BBC News website (UK)
Comment: To learn more about the concept of net neutrality and understand why it is important, visit the Save the Internet website.

April 13, 2011

Number of patent applications in Europe hits all-time high
The European patent office (EPO) says that the number of applications for patents has risen sharply in the past year.
Read article at theparliament.com
Comment: A particularly malicious aspect of patents is that they are being used to form global corporate cartels beyond any national or international legislative control. Large multi-national companies do not need to formally unite in order to control the market for a certain product across a continent or the entire world – they simply need to stake out their territorial patent claims. As a result, patents are the key economic tools of the Brussels EU; in particular, patents on chemicals, pharmaceutical drugs, genetically-modified seeds and other high-tech products. Significantly, therefore, the EPO’s annual report states that European firms continue to be the "champions" of patent protection in their home market, with a former IG Farben member, Germany’s BASF, being one of the three most prolific applicants in 2010 and medical technology topping the list of categories with 10,500 applications. The strongest growth rates are reported to be in biotechnology-related filings - which increased 42.6% to 7,400 applications in 2010 - and pharmaceuticals, which went up 20% to reach 6,700 filings.

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.

 

Back to the Newsletter Archive…